The turn in the case is witnessed as QT Vascular said the United States Court of Appeals for the Federal Circuit has reversed a district court ruling for the Singapore-listed company to pay more than US$20 million in damages to AngioScore Inc on ... 4 Traders, 3 hours ago
Induced Infringement Becomes More Difficult To Defend - JD Supra, 5 hours ago
QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment - BioSpace, 8 hours ago
More from: Healio, Equities.com...and 41 other sources
A federal judge has officially denied AstraZeneca's bid for seven more years of patent exclusivity by way of orphan drug legislation for its blockbuster drug Crestor (rosuvastatin). According to July 19, 2016 decision, the court refused to issue a ...PharmTech.com, 3 days ago AstraZeneca loses court battle to prevent generic versions of Crestor StatNews.com, 5 days ago Judge refuses to block generic versions of AstraZeneca's Crestor London South East, 5 days ago
The Spectranetics Corporation (NASDAQ: SPNC ) revealed Thursday that the Court of Appeals for the Federal Circuit in the United States reversed in part, as well as affirmed in part trial court rulings in respect of patent infringement. This was ...Benzinga.com, 4 days ago Federal Circuit Saves 10k Patents By Reversing District Court Decision In Immersion Corp V HTC JD Supra, 1 week ago Ruling From Federal Appeals Court Upholds Broad Use Of Biotech Patents Kaiser Health News, 2 weeks ago
Prince Joel Odoh, the National President of NAPPMED The Federal High Court, Akure has dismissed the suit filed by the Nigeria Association of Patent and Proprietary Medicine Dealers (NAPPMED) against the Pharmacists Council of Nigeria (PCN). ...The Guardian Nigeria, 6 days ago Court dismisses drug vendors case against PCN The Nation Nigeria, 1 week ago Court Dismisses NAPPMED's Case against PCN This Day Online, 1 week ago High Court dismisses NAPPMED suit against PCN Vanguard, 1 week ago
More from: ForNaija.com, Uncova...and 5 other sources
A + By Mikey Campbell Friday, July 22, 2016, 05:10 pm PT (08:10 pm ET) The U.S. Court of Appeals for the Federal Circuit on Friday handed down an opinion vacating in part a 2015 summary judgment that found Apple not in infringement of certain ...Apple Insider, 2 days ago U.S. Supreme Court to hear Samsung's appeal of Apple design patent case on October 11th Mac Daily News, 1 week ago Supreme Court to hear Apple v. Samsung appeal on Oct. 11 Apple Insider, 1 week ago Supreme Court affirms non-appealable nature of institution decisions and use of broadest reasonable construction standard Lexology, 1 week ago
180-Day Notice of Commercial Marketing Mandatory Even When Biosimilar Applicants Do the "Patent Dance"
, the Federal Circuit issued another important decision regarding the meaning of certain provisions of the Biologics Price Competition and Innovation Act of 2009 ("BPCIA"). See Amgen Inc. v. Apotex Inc ., Fed. Cir. Case No. 2016-1308 (Fed. Cir.Lexology, 1 week ago Biosimilar Patent Dance Does Not Permit Sidestepping of 180-Day Notice JD Supra, 1 week ago Federal Circuit Holds Again That BPCIA's 180-day Notice Is Mandatory JD Supra, 2 weeks ago Federal Court Weighs in on Biosimilar Patent Dance BioPharm International, 2 weeks ago
This is a tale of two former bodybuilders, facing off in court — over a patent. And not just any patent: Based on federally funded research, this one has a pedigree that links back to one of the most prestigious universities in the world. And ...NPR, 2 weeks ago
Enzo Biochem's Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware With Illumina, Inc.
Resolved Suit Is One of 11 Infringement Cases Brought in Delaware Federal District Court ; Six Remain Pending NEW YORK, NY -- Enzo Biochem, Inc. (NYSE:ENZ) today announced that its subsidiary, Enzo Life Sciences, Inc. , has reached and ...Equities.com, 2 weeks ago ENZO BIOCHEM : Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware With Illumina, Inc. 4 Traders, 2 weeks ago Enzo Biochem???s Life Sciences Unit Reaches $21 Million Patent Infringement Settlement In Delaware With Illumina BioSpace, 2 weeks ago Enzo Biochem 's Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware With Illumina, Inc. Stockwatch, 2 weeks ago
- Patented Medicine Prices Review Board In a decision dated June 23, 2016, Canada's Federal Court dismissed a constitutional challenge brought against the Patented Medicine Prices Review Board (PMPRB), an agency created by the federal government to ...4 Traders, 2 weeks ago
Since the Supreme Court decided Alice Corp. v. CLS Bank International, patent examiners and the courts have been working to better define patent eligibility. Following closely on the heels of their Enfish, LLC, v. Microsoft Corporation decision, the ...JD Supra, 3 days ago Review of Recent IP Supreme Court Cases SlideShare.net, 6 hours ago In Halo Electronics v. Pulse Electronics, Supreme Court Strikes Down Seagate Test for Enhanced Damages Under Section 284 of the Patent Act. JD Supra, 3 days ago Supreme Court Denies Sequenom Petition Clinical Lab Products, 1 week ago
More from: , G2 Intelligence...and 3 other sources
on your WebpageAdd Widget >Get your members hooked!